Art

J-GLOBAL ID：201702277077140506   Reference number：17A0016855

Safety and efficacy of dual direct-acting antiviral therapy (daclatasvir and asunaprevir) for chronic hepatitis C virus genotype 1 infection in patients on hemodialysis

血液透析患者における慢性C型肝炎ウイルス遺伝子型1感染症に対する二重直接作用抗ウイルス療法(ダクラタスビルおよびアスナプレビル)の安全性と有効性

Author (10)： Toyoda Hidenori (Ogaki Municipal Hospital) ,  Kumada Takashi (Ogaki Municipal Hospital) ,  Tada Toshifumi (Ogaki Municipal Hospital) ,  Takaguchi Koichi (Kagawa Prefectural Central Hospital) ,  Ishikawa Toru (Saiseikai Niigata Daini Hospital) ,  Tsuji Kunihiko (Teine Keijinkai Hospital) ,  Zeniya Mikio (International University of Health and Welfare) ,  Iio Etsuko (Nagoya City University Graduate School of Medical Science) ,  Iio Etsuko (Nagoya City University Graduate School of Medical Science) ,  Tanaka Yasuhito (Nagoya City University Graduate School of Medical Science)
Material： Journal of Gastroenterology  (J Gastroenterol)
Volume： 51  Issue： 7  Page： 741-747  Publication year： 2016 
JST Material Number： Z0748A  ISSN： 0944-1174  Document type： Article
Article type： 原著論文  Country of issue： Germany, Federal Republic of (DEU)  Language： ENGLISH (EN)

Thesaurus term： human(primates) ,...
Semi thesaurus term： *hepatitis C virus 1 ,...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=17A0016855&from=J-GLOBAL&jstjournalNo=Z0748A") }}

Author keywords (5)： Chronic hepatitis C ,  Direct-acting antiviral drugs ,  Hemodialysis ,  Safety ,  Viral response

JST classification (1)： Drug therapy(=pharmacotherapy)for digestive system diseases  (GH05020G)

Substance index (2)： BMS-650032 ,  BMS-790052

Reference (39)：

• Berenguer M. Treatment of chronic hepatitis C in hemodialysis patients. Hepatology. 2008;48(5):1690-9.
• Fabrizi F, Poordad FF, Martin P. Hepatitis C infection and the patient with end-stage renal disease. Hepatology. 2002;36(1):3-10.
• Martin P, Fabrizi F. Hepatitis C virus and kidney disease. J Hepatol. 2008;49(4):613-24.
• Liu CH, Kao JH. Treatment of hepatitis C virus infection in patients with end-stage renal disease. J Gastroenterol Hepatol. 2011;26(2):228-39.
• Stehman-Breen CO, Emerson S, Gretch D, et al. Risk of death among chronic dialysis patients infected with hepatitis C virus. Am J Kidney Dis. 1998;32(4):629-34.

Terms in the title (9)： 血液透析患者 ,  慢性 ,  C型肝炎ウイルス遺伝子型 ,  感染症 ,  抗ウイルス療法 ,  ダクラタスビル ,  アスナプレビル ,  安全性 ,  有効性